Hangzhou Tigermed Consulting Co (SZSE:300347) LT-Debt-to-Total-Asset : 0.03 (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Hangzhou Tigermed Consulting Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.03.

Hangzhou Tigermed Consulting Co's long-term debt to total assets ratio increased from Mar. 2023 (0.03) to Mar. 2024 (0.03). It may suggest that Hangzhou Tigermed Consulting Co is progressively becoming more dependent on debt to grow their business.

Hangzhou Tigermed Consulting Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co LT-Debt-to-Total-Asset Chart

Hangzhou Tigermed Consulting Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.02

0.01

0.02

0.03

Hangzhou Tigermed Consulting Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.03	0.03	0.03	0.03

Hangzhou Tigermed Consulting Co LT-Debt-to-Total-Asset Calculation

Hangzhou Tigermed Consulting Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	857.332	/	29680.742
	=	0.03

Hangzhou Tigermed Consulting Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	842.239	/	30070.185
	=	0.03

Hangzhou Tigermed Consulting Co (SZSE:300347) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Hangzhou Tigermed Consulting Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

HNGZY:USA 03347:Hong Kong

Address

Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053

Website

https://www.tigermed.net

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Executives

	Directors, executives
Cao Xiao Chun	Directors, executives
	Executives
Ye Xiao Ping	Director
Shi Xiao Li	Supervisors
Wang Xiao Bo	Supervisors
Li Xiao Ri	Securities Affairs Representative
Xu Jia Lian	Executives
Gong Yan Hua	Director

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines